Table 4. Data of relapsed patients both at diagnosis and at relapse.

	Treatment	Time to relapse*	At diagnosis	At relapse
			CD20+/CD3+/FOXP3+	CD20+/CD3+/FOXP3+
Patient 1	HP	3	700/114/28	1110/30/29
Patient 2	F	5	800/186/100	628/250/210
Patient 3	HP	23	750/184/67	700/130/37
Patient 4	Chemo	31	660/125/1	855/70/10

HP: erradication therapy; F: Fludarabine; Chemo: Chemotherapy.

^*Time to relapse in months.